Low-Dose, Once-Daily Atazanavir/Ritonavir (200/100): An Effective Treatment for HIV-Infected Patients in Thailand-Reference-Cited by-同舟云学术

Low-Dose, Once-Daily Atazanavir/Ritonavir (200/100): An Effective Treatment for HIV-Infected Patients in Thailand

Published:2008-10 Issue:2 Volume:49 Page:230-231
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Chetchotisakd Ploenchan,Anunnatsiri Siriluck

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference2 articles.

1. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts 200 cells/mm3: 96-week outcomes.;Mootsikapun;Antivir Ther,2005

2. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.;Poirier;AIDS,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis;Drug Metabolism and Pharmacokinetics;2022-12

2. Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults;Antiviral Therapy;2018

3. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients;International Journal of Antimicrobial Agents;2017-03

4. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial;The Lancet HIV;2016-08

5. Pharmacogenetic Testing Can Identify Patients Taking Atazanavir at Risk for Hyperbilirubinemia;JAIDS Journal of Acquired Immune Deficiency Syndromes;2015-05-01